The Market in Mind (notice n° 15657)

détails MARC
000 -LEADER
fixed length control field 02658cam a2200277zu 4500
003 - CONTROL NUMBER IDENTIFIER
control field FRCYB88871954
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250107105106.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 250107s2019 fr | o|||||0|0|||eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780262536875
035 ## - SYSTEM CONTROL NUMBER
System control number FRCYB88871954
040 ## - CATALOGING SOURCE
Original cataloging agency FR-PaCSA
Language of cataloging en
Transcribing agency
Description conventions rda
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Robinson, Mark Dennis
245 01 - TITLE STATEMENT
Title The Market in Mind
Remainder of title How Financialization Is Shaping Neuroscience, Translational Medicine, and Innovation in Biotechnology
Statement of responsibility, etc. ['Robinson, Mark Dennis']
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Name of producer, publisher, distributor, manufacturer MIT Press
Date of production, publication, distribution, manufacture, or copyright notice 2019
300 ## - PHYSICAL DESCRIPTION
Extent p.
336 ## - CONTENT TYPE
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type code c
Source rdamdedia
338 ## - CARRIER TYPE
Carrier type code c
Source rdacarrier
520 ## - SUMMARY, ETC.
Summary, etc. A critical examination of translational medicine, when private risk is transferred to the public sector and university research teams become tech startups for global investors.A global shift has secretly transformed science and medicine. Starting in 2003, biomedical research in the West has been reshaped by the emergence of translational science and medicine?the idea that the aim of research is to translate findings as quickly as possible into medical products. In The Market in Mind, Mark Dennis Robinson charts this shift, arguing that the new research paradigm has turned university research teams into small biotechnology startups and their industry partners into early-stage investment firms. There is also a larger, surprising consequence from this shift: according to Robinson, translational science and medicine enable biopharmaceutical firms, as part of a broader financial strategy, to outsource the riskiest parts of research to nonprofit universities. Robinson examines the implications of this new configuration. What happens, for example, when universities absorb unknown levels of risk? Robinson argues that in the years since the global financial crisis translational science and medicine has brought about ?the financialization of health.?Robinson explores such topics as shareholder anxiety and industry retreat from Alzheimer's and depression research; how laboratory research is understood as health innovation even when there is no product; the emergence of investor networking events as crucial for viewing science in a market context; and the place of patients in research decisions. Although translational medicine justifies itself by the goal of relieving patients' suffering, Robinson finds patients' voices largely marginalized in translational neuroscience.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Robinson, Mark Dennis
856 40 - ELECTRONIC LOCATION AND ACCESS
Access method Cyberlibris
Uniform Resource Identifier <a href="https://international.scholarvox.com/netsen/book/88871954">https://international.scholarvox.com/netsen/book/88871954</a>
Electronic format type text/html
Host name

Pas d'exemplaire disponible.

PLUDOC

PLUDOC est la plateforme unique et centralisée de gestion des bibliothèques physiques et numériques de Guinée administré par le CEDUST. Elle est la plus grande base de données de ressources documentaires pour les Étudiants, Enseignants chercheurs et Chercheurs de Guinée.

Adresse

627 919 101/664 919 101

25 boulevard du commerce
Kaloum, Conakry, Guinée

Réseaux sociaux

Powered by Netsen Group @ 2025